Product Information
TREXALL 5 MG TABLET is a brand (anda) product labeled by Teva Women's Health, Inc., priced at $24.0884 per EA under NDC 51285036601. Its NADAC has been published 83 times since Jan 22, 2025.
FDA first approved this application on Mar 21, 2001.
The High Outlier badge above means this manufacturer's average price in the Methotrexate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Teva Women's Health, Inc.NDC
51285036601
Classification
Brand (ANDA)
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
METHOTREXATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA040385FDA Approved
3/21/2001
On Market Since
5/3/2001
Pharmacological Classes
Price Statistics
The NADAC for TREXALL 5 MG TABLET has been published 83 times since Jan 22, 2025, and over the history we have for it it has risen 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $24.0884 per EA |
|---|---|
| All-time high | $24.0884 (Aug 19, 2026) |
| All-time low | $22.0187 (Jan 22, 2025) |
| 52-week high | $24.0884 |
| 52-week low | $22.0187 |
| Median price | $22.0187 |
| Average price | $22.8416 |
| Largest weekly change | +9.4% (Jan 7, 2026) |
| Weeks tracked | 83 |
| Tracking since | Jan 22, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Methotrexate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TREXALL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TREXALL 5 MG TABLET, manufactured by Teva Women's Health, Inc., is $24.0884 per EA (NDC 51285036601), effective Aug 19, 2026.
How has the price of TREXALL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for TREXALL 5 MG TABLET has risen 9.4%. It has been tracked across 83 weekly CMS publications since Jan 22, 2025.
What are the highest and lowest recorded NADAC prices for TREXALL 5 MG TABLET?
Since Jan 22, 2025, the NADAC for TREXALL 5 MG TABLET has ranged from a low of $22.0187 (Jan 22, 2025) to a high of $24.0884 (Aug 19, 2026), with a median of $22.0187 per EA.
Are there cheaper alternatives to TREXALL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of TREXALL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TREXALL 5 MG TABLET?
TREXALL 5 MG TABLET (NDC 51285036601) is labeled by Teva Women's Health, Inc., and CMS classifies it as a brand (anda) product.